Notably, glioma cells harboring p53 mutations often exhibit elevated ZDHHC5 protein levels, likely due to cooperative effects between mutated p53 and the nuclear transcription factor NF-Y, which may enhance ZDHHC5 expression. This evidence concerns the gene ZDHHC5 and central nervous system cancer.